Freeman Mason

Insider profile

Performance

Overall performance
3.3

Performance over holding periods
3.3
30 days 90 days 120 days
Average return 49% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Freeman Mason's trades of CinCor Pharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-02-27 2022-06-10 S Sale
94,830 -14.2%
308.69
US$916,245
94,830 -14.2% 308.69 US$916,245
2022-01-13 2022-01-11 B Purchase
4,002 +10.1%
167.47
US$4,476,583
4,002 +10.1% 167.47 US$4,476,583
2022-01-13 2022-01-11 B Purchase
34,396 +27.8%
494.90
US$4,609,577
34,396 +27.8% 494.90 US$4,609,577